Nov. 20, 2018

Although monogenic disorders of the beta cell account for only 1–2% of all diabetes, they are bound to show up sometime in your practice. They are discrete disorders that are a significant cause of diabetes in their own right. This week, in our Clinical Text, we begin a discussion of the three major types, with an overview of MODY. If you want to learn more about monogenic disorders in general, check out Part 1 from last week’s Clinical Text.

Also, our Medical Editor, Joy Pape, RN, MSN, FNP, CDE, FAADE spent last week in Nashville for the joint collaboration of The Obesity Society’s (TOS) and the American Society for Metabolic & Bariatric Surgery’s (ASMBS) Obesity Week 2018.  ObesityWeek brings together world-renowned experts in obesity to share innovation and breakthroughs in science unmatched around the globe. This year, the international conference focused on the heart, the cardiac component of obesity, and of course a lot of information regarding diabetes.

Today, we share her interview with Dr. Scott Kahan MD, MPH, Director of the National Center for Weight and Wellness, Faculty at Johns Hopkins Bloomberg School of Public Health, from the American Association of Clinical Endocrinologist’s (AACE) 2018 annual meeting. Who recently accepted the position of joining DiabetesInControl’s Advisory Board.

Joy and Dr. Kahan look forward to share evidence based science about the disease of obesity and scientifically sound treatments to help you and your patients differentiate between the hype and evidence based treatment strategies.

Dave Joffe

Editor-in-chief